PMV Pharmaceuticals Inc

NASDAQ:PMVP   3:59:52 PM EDT
14.05
+0.33 (+2.40%)
Earnings Announcements

Pmv Pharmaceuticals Reports First Quarter 2022 Financial Results And Corporate Highlights

Published: 05/10/2022 11:37 GMT
PMV Pharmaceuticals Inc (PMVP) - Pmv Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights.
Qtrly Loss per Share $0.41.
As of March 31, 2022, Co. Had $294.8 Million in Cash, Cash Equivalents, and Marketable Securities.
Q1 Earnings per Share View $-0.40 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.